Medplus Subsidiary Receives Drug License Suspension Order
Medplus Health Services Limited announced that Optival Health Solutions Private Limited, a subsidiary of the company, has received a suspension order for a Drug License affecting one of its stores. The order, received on April 2, 2026, pertains to a store located on Station Road in Jangaon, Telangana.The Drug License for the store has been suspended for a period of two days. The suspension is based on a violation of Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
Medplus estimates the potential revenue loss resulting from the suspension to be Rs 0.16 lacs.
Further details regarding the matter are available on the company website, www.medplusindia.com, as well as on the websites of the BSE Limited and the National Stock Exchange of India Ltd.
Manoj Kumar Srivastava, Company Secretary & Compliance Officer, provided the update.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.